Documentary AreaSimply the best Documentaries

Can love change the world? Morgan Freeman is on a global quest to understand how this primal force binds us together as a species. From orphanages to battlefields, from arranged marriages to life on the streets, Freeman sees how love can be found in unexpected places and how this force inspires us all.

Can we bridge the divide between 'us' and 'them'? At a time when the whole world seems to be polarizing into irreconcilable camps, Morgan Freeman sets out on a journey in search of the forces that push us apart, from intolerance of differences to fear of outsiders, and the possibilities of coming together.

Can we find a way to distribute power so that everyone has their say? A U.S. president explains the challenges of making decisions that affect hundreds of millions of lives, and Freeman learns about an African woman who has created a society without men. He explores how the rise of the internet may fundamentally change how democracy works.

Freeman's quest to understand what makes a rebellion successful brings him face-to-face with exiles, whistle blowers, hackers and movement leaders. From Berlin to Bolivia to the United States, he'll see the courage, dedication, hard work and hope that it takes to try to change the world.

Targeting unsuspecting Americans, a group of payday lenders made millions off small loans with undisclosed charges, inflated interest rates and incomprehensible rules. But the way the laws are written, is that a crime or just business?

Valeant Pharmaceuticals was a multinational specialty pharmaceutical company based in Canada. It grew rapidly through a series of mergers and acquisitions under the leadership of J. Michael Pearson. The company was involved in a number of controversies surrounding drug price hikes and the use of a specialty pharmacy for the distribution of its drugs, which led to an investigation by the U.S. Securities and Exchange Commission and caused its stock price to plummet more than 90 percent from its peak while its debt surpassed $30 billion.
Wall Street short-sellers exposed a scam that regulators overlook: how Big Pharma gouges patients in need of life-saving drugs.